Company: CORT
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001628280-25-022173
Chunk: 238

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-05-05
Form: 10-Q
Item: Part II, Item 5
Chunk 238
---
ITEM 5.  OTHER INFORMATION

Insider Trading Arrangements

During the three months ended March 31, 2025, no directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted, terminated, or modified any contract, instruction or written plan for the purchase or sales of our securities intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange or any “non-Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K.

39